Skip to content

Opko Health OPK Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total

Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total at other companies

Archrock logo
ArchrockAROC
$74.27M+4.8%
Restoration Hardware logo
Restoration HardwareRH
-$13.26M-7,885%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$116.33M-56.2%
Quaker Houghton logo
Quaker HoughtonKWR
$16.54M+68.3%
ExlService Holdings logo
ExlService HoldingsEXLS
$67.08M+0.6%
Chart Industries logo
Chart IndustriesGTLS
-$14.2M-126%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+11.5%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept opk:IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's income loss from continuing operations net of tax before equity method investments and noncontrolling interest total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's income loss from continuing operations net of tax before equity method investments and noncontrolling interest total?
Opko Health (OPK) reported income loss from continuing operations net of tax before equity method investments and noncontrolling interest total of -$54.85M in Q1 2026.
How has Opko Health's income loss from continuing operations net of tax before equity method investments and noncontrolling interest total changed year-over-year?
Opko Health's income loss from continuing operations net of tax before equity method investments and noncontrolling interest total increased by 18.9% year-over-year, from -$67.6M to -$54.85M.
What is the long-term trend for Opko Health's income loss from continuing operations net of tax before equity method investments and noncontrolling interest total?
Over 3 years (2021 to 2025), Opko Health's income loss from continuing operations net of tax before equity method investments and noncontrolling interest total has grown at a 97.0% compound annual growth rate (CAGR), from -$29.51M to -$225.65M.
What does income loss from continuing operations net of tax before equity method investments and noncontrolling interest total mean?
This metric represents the net earnings or losses generated from the company's core business activities, excluding the impact of equity method investments and noncontrolling interests. It provides a focused view of the profitability of the firm's ongoing operations before accounting for minority ownership stakes. This figure is essential for assessing the underlying financial health and operational viability of the primary business segments.